Template:KDRG: Difference between revisions

Jump to navigation Jump to search
Created page with "Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com]"
 
No edit summary
Line 1: Line 1:
[[User:Kosar Doraghi|Kosar Doraghi, M.D.]][mailto:k.doraghi@yahoo.com]
[[User:Kosar Doraghi|Kosar Doraghi, M.D.]][mailto:k.doraghi@yahoo.com]
=Kosar Doraghi, M.D.=
==Current Position==
'''Associate Editor-in-Chief,''' Beth Israel Deaconess Medical Center by Harvard Medical School, Boston, Massachusetts, USA, WikiDoc Scholar
==Pages Authored/Co-authored/Collaborated==
<div style="-moz-column-count:8; column-count:3;">
#[[NEXOBRID]]
#[[RELYVRIO]]
#[[Deucravacitinib]]
#[[Ublituximab-xiiy]]
#[[futibatinib]]
#[[Tapinarof]]
#[[Spevigo- spesolimab-sbz]]
#[[Vericiguat]]
#[[Dasiglucagon]]
#[[Ponesimod]]
#[[Lasmiditan]]
#[[Nirogacestat]]
#[[Nedosiran]]

Revision as of 20:44, 24 February 2024

Kosar Doraghi, M.D.[1]

Kosar Doraghi, M.D.

Current Position

Associate Editor-in-Chief, Beth Israel Deaconess Medical Center by Harvard Medical School, Boston, Massachusetts, USA, WikiDoc Scholar


Pages Authored/Co-authored/Collaborated

  1. NEXOBRID
  2. RELYVRIO
  3. Deucravacitinib
  4. Ublituximab-xiiy
  5. futibatinib
  6. Tapinarof
  7. Spevigo- spesolimab-sbz
  8. Vericiguat
  9. Dasiglucagon
  10. Ponesimod
  11. Lasmiditan
  12. Nirogacestat
  13. Nedosiran